ChargePoint (CHPT) 10-Q 11 Sep 23 2024 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jul. 31, 2023	Aug. 31, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2023
Document Transition Report	false
Entity File Number	001-39004
Entity Registrant Name	ChargePoint Holdings, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	84-1747686
Entity Address, Address Line One	240 East Hacienda Avenue
Entity Address, City or Town	Campbell
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95008
City Area Code	408
Local Phone Number	841-4500
Title of 12(b) Security	Common Stock, par value $0.0001
Trading Symbol	CHPT
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		360,053,986
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--01-31
Entity Central Index Key	0001777393

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Jul. 31, 2023	Jan. 31, 2023
Current assets:
Cash and cash equivalents	$ 233,499,000	$ 264,162,000
Restricted cash	30,400,000	30,400,000
Short-term investments	0	104,966,000
Accounts receivable, net of allowance of $13,000 as of July 31, 2023 and $10,000 as of January 31, 2023	202,079,000	164,892,000
Inventories	143,580,000	68,730,000
Prepaid expenses and other current assets	82,657,000	71,020,000
Total current assets	692,215,000	704,170,000
Property and equipment, net	42,736,000	40,046,000
Intangible assets, net	87,924,000	92,673,000
Operating lease right-of-use assets	20,164,000	22,242,000
Goodwill	216,615,000	213,716,000
Other assets	8,734,000	7,110,000
Total assets	1,068,388,000	1,079,957,000
Current liabilities:
Accounts payable	99,024,000	62,076,000
Accrued and other current liabilities	145,725,000	133,483,000
Deferred revenue	95,800,000	88,777,000
Total current liabilities	340,549,000	284,336,000
Deferred revenue, noncurrent	124,042,000	109,833,000
Debt, noncurrent	295,539,000	294,936,000
Operating lease liabilities	19,544,000	21,841,000
Deferred tax liabilities	11,868,000	12,987,000
Other long-term liabilities	1,626,000	1,032,000
Total liabilities	793,168,000	724,965,000
Commitments and contingencies (Note 8)
Stockholders’ equity:
Common stock: $0.0001 par value; 1,000,000,000 shares authorized as of July 31, 2023 and January 31, 2023; 359,792,252 and 348,330,481 shares issued and outstanding as of July 31, 2023 and January 31, 2023, respectively	36,000	35,000
Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of July 31, 2023 and January 31, 2023; 0 issued and outstanding as of July 31, 2023 and January 31, 2023	0	0
Additional paid-in capital	1,648,198,000	1,528,104,000
Accumulated other comprehensive loss	(11,608,000)	(16,384,000)
Accumulated deficit	(1,361,406,000)	(1,156,763,000)
Total stockholders’ equity	275,220,000	354,992,000
Total liabilities and stockholders’ equity	$ 1,068,388,000	$ 1,079,957,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Current assets:
Allowance for credit loss	$ 13,000	$ 10,000
Stockholders’ equity:
Common stock, par value (in USD per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	359,792,252	348,330,481
Common stock, shares outstanding (in shares)	359,792,252	348,330,481
Preferred stock, par value (in USD per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Revenue
Total revenue	$ 150,494	$ 108,292	$ 280,523	$ 189,925
Cost of revenue
Total cost of revenue	149,369	90,139	248,863	159,665
Gross profit	1,125	18,153	31,660	30,260
Operating expenses
Research and development	59,642	51,804	109,039	100,105
Sales and marketing	39,671	33,873	76,711	66,460
General and administrative	25,144	22,846	49,164	43,893
Total operating expenses	124,457	108,523	234,914	210,458
Loss from operations	(123,332)	(90,370)	(203,254)	(180,198)
Interest income	1,840	1,460	4,300	1,566
Interest expense	(2,926)	(2,928)	(5,853)	(3,862)
Change in fair value of common stock warrant liabilities	0	0	0	(24)
Other income (expense), net	68	(1,254)	642	(1,702)
Net loss before income taxes	(124,350)	(93,092)	(204,165)	(184,220)
Provision for (benefit from) income taxes	905	(392)	478	(2,254)
Net loss	$ (125,255)	$ (92,700)	$ (204,643)	$ (181,966)
Weighted average shares outstanding - basic (in shares)	355,876,807	336,813,555	353,008,473	335,736,772
Weighted average shares outstanding - diluted (in shares)	355,876,807	336,813,555	353,008,473	335,736,772
Net loss per share - basic (in USD per share)	$ (0.35)	$ (0.28)	$ (0.58)	$ (0.54)
Net loss per share - diluted (in USD per share)	$ (0.35)	$ (0.28)	$ (0.58)	$ (0.54)
Networked charging systems
Revenue
Total revenue	$ 114,574	$ 84,148	$ 212,894	$ 143,699
Cost of revenue
Total cost of revenue	126,961	74,352	207,883	130,618
Subscriptions
Revenue
Total revenue	30,011	20,244	56,376	37,890
Cost of revenue
Total cost of revenue	18,692	13,278	33,497	23,905
Other
Revenue
Total revenue	5,909	3,900	11,253	8,336
Cost of revenue
Total cost of revenue	$ 3,716	$ 2,509	$ 7,483	$ 5,142

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (125,255)	$ (92,700)	$ (204,643)	$ (181,966)
Other comprehensive income (loss):
Foreign currency translation adjustment	185	(6,562)	4,327	(19,502)
Reclassification adjustment for net realized gains on short-term investments included in net income, net of tax	0	0	449	0
Unrealized loss on short-term investments, net of tax	0	(1,303)	0	(1,303)
Other comprehensive income (loss)	185	(7,865)	4,776	(20,805)
Comprehensive loss	$ (125,070)	$ (100,565)	$ (199,867)	$ (202,771)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Common stock, shares outstanding, beginning balance (in shares) at Jan. 31, 2022		334,760,615
Beginning balance at Jan. 31, 2022	$ 547,014	$ 33	$ 1,366,855	$ (8,219)	$ (811,655)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans, net of tax withholding (in shares)		1,631,104
Issuance of common stock under stock plans, net of tax withholding	773	$ 1	772
Issuance of common stock upon ESPP purchase (in shares)		263,962
Issuance of common stock upon ESPP purchase	3,920		3,920
Issuance of common stock upon exercise of warrants (in shares)		16,948
Issuance of common stock upon exercise of warrants	48		48
Vesting of early exercised stock options	17		17
Stock-based compensation	15,527		15,527
Net loss	(89,266)				(89,266)
Other comprehensive income (loss)	(12,941)			(12,941)
Common stock, shares outstanding, ending balance (in shares) at Apr. 30, 2022		336,672,629
Ending balance at Apr. 30, 2022	465,092	$ 34	1,387,139	(21,160)	(900,921)
Common stock, shares outstanding, beginning balance (in shares) at Jan. 31, 2022		334,760,615
Beginning balance at Jan. 31, 2022	547,014	$ 33	1,366,855	(8,219)	(811,655)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(181,966)
Other comprehensive income (loss)	(20,805)
Common stock, shares outstanding, ending balance (in shares) at Jul. 31, 2022		338,820,463
Ending balance at Jul. 31, 2022	391,689	$ 34	1,414,301	(29,025)	(993,621)
Common stock, shares outstanding, beginning balance (in shares) at Apr. 30, 2022		336,672,629
Beginning balance at Apr. 30, 2022	465,092	$ 34	1,387,139	(21,160)	(900,921)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon release of restricted stock units (in shares)		2,147,834
Issuance of common stock upon release of restricted stock units	728		728
Vesting of early exercised stock options	15		15
Stock-based compensation	26,419		26,419
Net loss	(92,700)				(92,700)
Other comprehensive income (loss)	(7,865)			(7,865)
Common stock, shares outstanding, ending balance (in shares) at Jul. 31, 2022		338,820,463
Ending balance at Jul. 31, 2022	$ 391,689	$ 34	1,414,301	(29,025)	(993,621)
Common stock, shares outstanding, beginning balance (in shares) at Jan. 31, 2023	348,330,481	348,330,481
Beginning balance at Jan. 31, 2023	$ 354,992	$ 35	1,528,104	(16,384)	(1,156,763)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans, net of tax withholding (in shares)		2,278,764
Issuance of common stock under stock plans, net of tax withholding	915		915
Issuance of common stock upon ESPP purchase (in shares)		562,829
Issuance of common stock upon ESPP purchase	4,875		4,875
Issuance of common stock in connection with ATM offerings, net of issuance costs (in shares)		1,909,028
Issuance of common stock in connection with ATM offerings, net of issuance costs	17,516		17,516
Vesting of early exercised stock options	14		14
Stock-based compensation	23,964		23,964
Net loss	(79,388)				(79,388)
Other comprehensive income (loss)	4,591			4,591
Common stock, shares outstanding, ending balance (in shares) at Apr. 30, 2023		353,081,102
Ending balance at Apr. 30, 2023	$ 327,479	$ 35	1,575,388	(11,793)	(1,236,151)
Common stock, shares outstanding, beginning balance (in shares) at Jan. 31, 2023	348,330,481	348,330,481
Beginning balance at Jan. 31, 2023	$ 354,992	$ 35	1,528,104	(16,384)	(1,156,763)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(204,643)
Other comprehensive income (loss)	$ 4,776
Common stock, shares outstanding, ending balance (in shares) at Jul. 31, 2023	359,792,252	359,792,252
Ending balance at Jul. 31, 2023	$ 275,220	$ 36	1,648,198	(11,608)	(1,361,406)
Common stock, shares outstanding, beginning balance (in shares) at Apr. 30, 2023		353,081,102
Beginning balance at Apr. 30, 2023	327,479	$ 35	1,575,388	(11,793)	(1,236,151)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans, net of tax withholding (in shares)		2,635,078
Issuance of common stock under stock plans, net of tax withholding	420		420
Issuance of common stock in connection with ATM offerings, net of issuance costs (in shares)		4,076,072
Issuance of common stock in connection with ATM offerings, net of issuance costs	37,284	$ 1	37,283
Vesting of early exercised stock options	8		8
Stock-based compensation	35,099		35,099
Net loss	(125,255)				(125,255)
Other comprehensive income (loss)	$ 185			185
Common stock, shares outstanding, ending balance (in shares) at Jul. 31, 2023	359,792,252	359,792,252
Ending balance at Jul. 31, 2023	$ 275,220	$ 36	$ 1,648,198	$ (11,608)	$ (1,361,406)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022
Cash flows from operating activities
Net loss	$ (204,643)	$ (181,966)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	14,018	12,476
Non-cash operating lease cost	2,199	2,451
Stock-based compensation	59,063	41,946
Amortization of deferred contract acquisition costs	1,380	1,118
Impairment	28,000	0
Reserves and other	5,026	5,015
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net	(40,562)	(36,178)
Inventories	(97,906)	(18,239)
Prepaid expenses and other assets	(12,365)	(9,964)
Accounts payable, operating lease liabilities, and accrued and other liabilities	33,957	28,896
Deferred revenue	21,231	20,773
Net cash used in operating activities	(190,602)	(133,672)
Cash flows from investing activities
Purchases of property and equipment	(9,877)	(8,872)
Maturities of investments	105,000	0
Purchases of short-term investments	0	(284,835)
Cash paid for acquisitions, net of cash acquired	0	(2,756)
Net cash provided by (used in) investing activities	95,123	(296,463)
Cash flows from financing activities
Proceeds from issuance of debt, net of discount and issuance costs	0	293,972
Debt issuance costs related to the revolving credit facility	(2,265)	0
Proceeds from the issuance of common stock under employee equity plans, net of tax withholding	6,212	5,419
Proceeds from issuance of common stock in connection with ATM offerings, net of issuance costs	54,799	0
Change in driver funds and amounts due to customers	8,839	4,238
Settlement of contingent earnout liability	(3,537)	0
Net cash provided by financing activities	64,048	303,629
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	768	(1,067)
Net increase in cash, cash equivalents, and restricted cash	(30,663)	(127,573)
Cash, cash equivalents, and restricted cash at beginning of period	294,562	315,635
Cash, cash equivalents, and restricted cash at end of period	263,899	188,062
Supplementary cash flow information
Cash paid for interest	5,250	0
Cash paid for taxes	547	197
Supplementary cash flow information on noncash investing and financing activities
Acquisitions of property and equipment included in accounts payable and accrued and other current liabilities	3,041	910
Vesting of early exercised stock options	21	32
Unpaid debt issuance costs	$ 507	$ 0

Description of Business and Bas

Description of Business and Basis of Presentation	6 Months Ended
	Jul. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business and Basis of Presentation	Description of Business and Basis of Presentation ChargePoint Holdings, Inc. (“ChargePoint” or the “Company,” “it,” “its”) designs, develops and markets networked electric vehicle (“EV”) charging system infrastructure (“Networked Charging Systems”), connected through cloud-based services (“Cloud” or “Cloud Services”) which (i) enable charging system owners, or hosts, to manage their Networked Charging Systems, and (ii) enable drivers to locate, reserve and authenticate Networked Charging Systems, and to transact EV charging sessions on those systems. ChargePoint’s Networked Charging Systems, subscriptions and other offerings provide an open platform that integrates with system hardware from ChargePoint and other manufacturers, connecting systems over an intelligent network that provides real-time information about charging sessions and full control, support and management of the Networked Charging Systems. This network also provides multiple web-based portals for charging system owners, fleet managers, drivers and utilities. In addition, the Company offers a range of extended warranties (“Assure”), as well as its ChargePoint as a Service (“CPaaS”) program which bundles use of ChargePoint owned and operated systems with Cloud Services, Assure and other benefits into one subscription. The Company’s fiscal year ends on January 31. References to fiscal year 2023 relate to the fiscal year ended January 31, 2023 and to fiscal year 2024 refer to the fiscal year ending January 31, 2024. Basis of Presentation The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reporting. The Company’s condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes for the year ended January 31, 2023 included in the Company’s Annual Report on Form 10-K filed with the SEC on April 3, 2023, which provides a more complete discussion of the Company’s accounting policies and certain other information. The information as of January 31, 2023, included on the condensed consolidated balance sheets was derived from the Company’s audited consolidated financial statements. The condensed consolidated financial statements were prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary for a fair statement of the Company’s financial position as of July 31, 2023, the results of operations for the three and six months ended July 31, 2023 and 2022, and cash flows for the six months ended July 31, 2023 and 2022. The results of operations for the three and six months ended July 31, 2023, are not necessarily indicative of the results that may be expected for the year ending January 31, 2024. The Company’s condensed consolidated financial statements have been prepared on the basis of continuity of operations, the realization of assets, and the satisfaction of liabilities in the ordinary course of business. Since inception, the Company has been engaged in developing and marketing its Networked Charging Systems, subscriptions and other offerings, raising capital, and recruiting personnel and it has incurred net operating losses and negative cash flows from operations in every year since inception and expects this to continue for the foreseeable future. As of July 31, 2023, the Company had an accumulated deficit of $1,361.4 million. The Company has funded its operations primarily with proceeds from the issuance of redeemable convertible preferred stock, convertible notes, exercise proceeds from options and warrants, borrowings under loan facilities, customer payments, proceeds from sale of Common Stock under the ATM Facility (as defined in Note 9, Common Stock ), and proceeds from the Reverse Recapitalization (as defined below). The Company had cash, cash equivalents and restricted cash of $263.9 million as of July 31, 2023. Cash outflow from operations was $190.6 million and $133.7 million for the six months ended July 31, 2023 and 2022, respectively. As of September 11, 2023, the date on which these condensed consolidated financial statements were issued, the Company believes that its cash on hand, together with cash generated from sales to customers, will satisfy its working capital and capital requirements for at least the next twelve months. The Company’s assessment of the period of time its financial resources will be adequate to support its operations is a forward-looking statement and involves risks and uncertainties. The Company’s actual results could vary as a result of, and its near- and long-term future capital requirements will depend on, many factors, including its growth rate, subscription renewal activity, the timing and extent of spending to support its acquisitions, infrastructure and research and development efforts, the expansion of sales and marketing activities, the timing of new introductions of products or features, the continuing market adoption of its Networked Charging Systems and Cloud Services platform, and the overall market acceptance of EVs. The Company has and may in the future enter into arrangements to acquire or invest in complementary businesses, services and technologies, including intellectual property rights. The Company has based its estimates on assumptions that may prove to be wrong, and it could use its available capital resources sooner than it currently expects. The Company may be required to seek additional equity or debt financing. Future liquidity and cash requirements will depend on numerous factors, including market penetration, the introduction of new products, and potential acquisitions of related businesses or technology. If additional financing is required from outside sources, the Company may not be able to raise it on acceptable terms or at all. If the Company is unable to raise additional capital when desired, or if it cannot expand its operations or otherwise capitalize on its business opportunities because it lacks sufficient capital, the Company may need to reorganize its operations including through further reductions in its workforce and its business, operating results and financial condition would be materially adversely affected. Reverse Recapitalization On February 26, 2021, Lightning Merger Sub Inc., a wholly-owned subsidiary of Switchback Energy Acquisition Corporation (“Switchback”), merged with ChargePoint, Inc. (“Legacy ChargePoint”), with Legacy ChargePoint surviving as a wholly-owned subsidiary of Switchback (the “Merger”). As a result of the Merger, Switchback was renamed “ChargePoint Holdings, Inc.” Immediately prior to the closing of the Merger (the “Closing”), Legacy ChargePoint’s outstanding series of redeemable convertible preferred stock were converted to Legacy ChargePoint common stock, which then converted to the Company’s common stock (“Common Stock”). The Merger is accounted for as a reverse capitalization in accordance with U.S. GAAP.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jul. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Other than policies noted below, there have been no significant changes to the significant accounting policies disclosed in Note 2 of the audited consolidated financial statements as of January 31, 2023 and 2022 and for the years ended January 31, 2023, 2022 and 2021 included in ChargePoint’s Annual Report on Form 10-K filed with the SEC on April 3, 2023. Use of Estimates The preparation of the accompanying condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers, the estimated expected benefit period for deferred contract acquisition costs, allowances for expected credit losses, inventory reserves, loss on purchase commitment, the useful lives of long-lived assets, the determination of the incremental borrowing rate used for operating lease liabilities, valuation of acquired goodwill and intangible assets, and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. Concentration of Credit Risk and Other Risks and Uncertainties Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are held in domestic and foreign cash accounts across large, creditworthy financial institutions. The Company has not experienced any losses on its deposits of cash and cash equivalents through deposits with federally insured commercial banks and at times cash deposit balances may be in excess of federal insurance limits. Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition. Concentration of credit risk with respect to trade accounts receivable is considered to be limited due to the diversity of the Company’s customer base and geographic sales areas. As of July 31, 2023, no customer individually accounted for 10% or more of accounts receivable, net. As of January 31, 2023, one customer individually accounted for 10% or more of accounts receivable, net. For the three months ended July 31, 2023, no customer individually represented 10% or more of total revenue. For the three months ended July 31, 2022, one customer accounted for 15% of total revenue. For the six months ended July 31, 2023 and July 31, 2022, no customer individually represented 10% or more of total revenue. The Company’s revenue is concentrated in the infrastructure needed for charging EVs, an industry which is highly competitive and rapidly changing. Significant technological changes within the industry or customer requirements, or the emergence of competitive products with new capabilities or technologies, could adversely affect the Company’s business, operating results and financial condition. Segment Reporting Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief decision maker (“CODM”). The Company operates as one operating segment because its Chief Executive Officer, as the Company’s CODM, reviews its financial information on a consolidated basis for purposes of making decisions regarding allocating resources and assessing performance. The Company has no segment managers who are held accountable by the CODM for operations, operating results, and planning for levels of components below the consolidated unit level. Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments with an original maturity of three months or less, when purchased, to be cash equivalents. Cash equivalents may be invested in money market funds. Cash and cash equivalents are carried at cost, which approximates their fair value. Restricted cash relates to cash deposits restricted under letters of credit issued in support of customer and contract manufacturer agreements. The reconciliation of cash, cash equivalents, and restricted cash to amounts presented in the consolidated condensed statements of cash flows was as follows: July 31, January 31, (in thousands) Cash and cash equivalents $ 233,499 $ 264,162 Restricted cash 30,400 30,400 Total cash, cash equivalents, and restricted cash $ 263,899 $ 294,562 Short-Term Investments The Company's portfolio of marketable debt securities is comprised solely of U.S. government securities with maturities of more than three months, but less than one year. The Company classifies these as available-for-sale at purchase date and will reevaluate such designation at each period end date. The Company may sell these marketable debt securities prior to their stated maturities depending upon changing liquidity requirements. These debt securities are classified as current assets in the condensed consolidated balance sheet and recorded at fair value, with unrealized gains or losses included in accumulated other comprehensive income (loss) and as a component of the condensed consolidated statements of comprehensive loss. Gains and losses are recognized when realized. Gains and losses are determined using the specific identification method and are reported in other income (expense), net in the condensed consolidated statements of operations. For available-for-sale debt securities in an unrealized loss position, the Company first assesses whether it intends to sell the security or it is more likely than not that the Company will be required to sell the security before the recovery of its entire amortized cost basis. If either of these criteria is met, the security’s amortized cost basis is written down to fair value through other income (expense), net in the consolidated statements of operations. If neither of these criteria is met, the Company evaluates whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. Credit related unrealized losses are recognized as an allowance for expected credit losses of available-for-sale debt securities on the consolidated balance sheets with a corresponding charge in other income (expense), net in the consolidated statements of operations. Non-credit related unrealized losses are included in accumulated other comprehensive income (loss). All of the short-term investments in U.S. Treasury securities have matured and no short-term investments remain outstanding since April 30, 2023. As of January 31, 2023, short-term investments consisted of the following: January 31, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value (in thousands) U.S. Treasury Securities $ 105,415 $ — $ (449) $ 104,966 Amortized cost and fair value amounts include accrued interest receivable of $0.5 million as of January 31, 2023. Fair Value of Financial Instruments Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets and liabilities measured at fair value are classified into the following categories based on the inputs used to measure fair value: • (Level 1) — Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date; • (Level 2) — Inputs other than quoted prices in active markets that are observable for the asset or liability, either directly or indirectly; and • (Level 3) — Inputs that are unobservable for the asset or liability. The Company classifies financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the asset or liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. There were no transfers between levels during the periods presented. The Company had no material non-financial assets valued on a non-recurring basis that resulted in an impairment in any period presented. The carrying values of the Company’s cash equivalents, accounts receivable, net, accounts payable, and accrued and other current liabilities approximate fair value based on the highly liquid, short-term nature of these instruments. Reclassifications of Prior Period Presentation Certain prior period amounts have been reclassified for consistency with the current year presentation. For the six months ended July 31, 2022, “operating lease liabilities,” “accounts payable,” and “accrued and other liabilities” were combined and presented as a single line item captioned “accounts payable, operating lease liabilities and accrued and other liabilities” within the net cash used in operating activities section of the condensed consolidated statements of cash flows instead of being separately stated as in prior period presentations. Accounting Pronouncements Recently Issued Accounting Standards Adopted In March 2022, the Financial Accounting Standards Board (“FASB”) issued ASU 2022-02, “ Financial Instruments—Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures,” which addresses areas identified by the FASB as part of its post-implementation review of ASU 2016-13, “ Financial Instruments--Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”) that introduced the current expected credit losses (“CECL”) model. The new guidance eliminates the accounting guidance for troubled debt restructurings by creditors that have already adopted the CECL model and enhances the disclosure requirements for loan refinancings and restructurings made with borrowers experiencing financial difficulty. In addition, the new guidance requires a public business entity to disclose current-period gross write-offs for financing receivables and net investment in leases by year of origination. The guidance is effective for public business entities that have adopted ASU 2016-13 for fiscal years beginning after December 31, 2022, including interim periods within those fiscal years. The Company adopted ASU 2022-02 on February 1, 2023 and elected to apply the amendments prospectively to all transactions within the scope of the amendment that are reflected in the financial statements at the date of adoption. The adoption did not have a material effect on the condensed consolidated financial statements and related disclosures.

Business Combinations

Business Combinations	6 Months Ended
	Jul. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Business Combinations	Business Combinations ViriCiti B.V. On August 11, 2021, the Company acquired all of the outstanding shares of ViriCiti B.V. (“ViriCiti”) for $79.4 million in cash, as well as $7.1 million of additional earnout consideration contingent on meeting certain revenue targets as of January 31, 2023 (“ViriCiti Earnout”), which additional consideration was paid in full on March 6, 2023. ViriCiti is a Netherlands-based provider of electrification solutions for eBus and commercial fleets with offices in the Netherlands and the United States. The acquisition is expected to enhance ChargePoint’s fleet solutions portfolio of hardware, software and services by integrating information sources to optimize electric fleet operations. has•to•be gmbh On October 6, 2021, the Company acquired all of the outstanding shares of has•to•be gmbh (“HTB”) for approximately $235.0 million, consisting of $132.9 million in cash and $102.1 million in the form of 5,695,176 shares of ChargePoint Common Stock valued at $17.92 per share on the acquisition date. Of the cash component, $2.8 million was paid on February 3, 2022 as part of a working capital adjustment, and of the shares, 885,692 shares, valued at $15.9 million, were held in escrow to cover indemnity claims the Company may make within eighteen months from the closing date and were released to former HTB shareholders in April 2023. HTB is an Austria-based e-mobility provider with a European charging software platform. The acquisition is intended to expand the Company’s market share in Europe.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
	Jul. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The following table summarizes the changes in carrying amounts of goodwill (in thousands): Balance as of January 31, 2023 $ 213,716 Foreign exchange fluctuations 2,899 Balance as of July 31, 2023 $ 216,615 There was no impairment recognized for the three and six months ended July 31, 2023 and 2022. The following table presents the details of intangible assets: July 31, 2023 Cost (1) Accumulated Amortization (1) Net (1) Useful Life (amounts in thousands, useful lives in years) Customer relationships $ 92,153 $ (17,017) $ 75,136 10 Developed technology 18,584 (5,796) 12,788 6 $ 110,737 $ (22,813) $ 87,924 _______________ (1) Values are translated into U.S. Dollars at period-end foreign exchange rates. January 31, 2023 Cost (1) Accumulated Amortization (1) Net (1) Useful Life (amounts in thousands, useful lives in years) Customer relationships $ 90,738 $ (12,223) $ 78,515 10 Developed technology 18,355 (4,197) 14,158 6 $ 109,093 $ (16,420) $ 92,673 _______________ (1) Values are translated into U.S. Dollars at period-end foreign exchange rates. Amortization expense for customer relationships and developed technology is shown as sales and marketing and cost of revenue, respectively, in the condensed consolidated statements of operations. The acquired intangible assets and goodwill are subject to impairment review at least annually on December 31st. Acquisition-related intangible assets included in the above table are finite-lived and are carried at cost less accumulated amortization. Intangible assets are being amortized on a straight-line basis over their estimated lives, which approximates the pattern in which the economic benefits of the intangible assets are expected to be realized. The following table presents the amortization expense related to intangible assets: Three Months Ended Six Months Ended 2023 2022 2023 2022 (in thousands) Amortization expense $ 3,039 $ 2,956 $ 6,077 $ 5,816

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jul. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows: Fair Value Measured as of July 31, 2023 Level 1 Level 2 Level 3 Total (in thousands) Assets Money market funds $ 2,343 $ — $ — $ 2,343 Total financial assets $ 2,343 $ — $ — $ 2,343 Fair Value Measured as of January 31, 2023 Level 1 Level 2 Level 3 Total (in thousands) Assets Money market funds $ 133,979 $ — $ — $ 133,979 U.S. Treasury securities — 104,966 — 104,966 Total financial assets $ 133,979 $ 104,966 $ — $ 238,945 The money market funds were classified as cash and cash equivalents on the condensed consolidated balance sheets and were within Level 1 of the fair value hierarchy. The aggregate fair value of the Company’s money market funds approximated amortized cost and, as such, there were no unrealized gains or losses on money market funds as of July 31, 2023 and January 31, 2023. Realized gains and losses, net of tax, were not material for any of the periods presented. Short-term investments, consisting of U.S. treasury securities, were classified as available-for-sale on purchase date and recorded at fair value on the condensed consolidated balance sheets. No short-term investments have been outstanding since April 30, 2023. The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments for the six months ended July 31, 2022: Private placement warrant liability ViriCiti Earnout liability (in thousands) Fair value as of January 31, 2022 $ (25) $ (5,993) Change in fair value included in other income (expense), net (23) — Effect of foreign currency translation — 505 Reclassification of warrants to stockholders’ equity (deficit) due to exercise 48 — Fair value as of July 31, 2022 $ — $ (5,488) No Level 3 financial instruments have been outstanding since January 31, 2023. Private Placement Liability The fair values of the private placement warrant liability are based on significant unobservable inputs, which represent Level 3 measurements within the fair value hierarchy. The significant unobservable inputs used in the fair value measurements of the private placement warrant liability include the expected volatility and dividend yield. In determining the fair value of the private placement warrant liability, the Company used the Binomial Lattice Model (“BLM”) that assumes optimal exercise of the Company's redemption option at the earliest possible date (see Note 10, Stock Warrants ). On February 21, 2022, the Company redeemed the remaining Private Placement Warrants for 0.355 shares of Common Stock per warrant. The Company recorded an immaterial loss during the three months ended April 30, 2022 classified within change in fair value of warrant liabilities in the condensed consolidated statements of operations. No Private Placement Warrants have been outstanding since April 30, 2022. ViriCiti Earnout Liability On August 11, 2021, the Company acquired all of the outstanding shares of ViriCiti. The purchase price consideration included the ViriCiti Earnout, which was consideration contingent on meeting certain revenue targets through January 31, 2023. The fair value of the ViriCiti Earnout liability was previously based on significant unobservable inputs, which represent Level 3 measurements within the fair value hierarchy. The ViriCiti Earnout liability was valued using a Monte Carlo simulation valuation model using a distribution of potential outcomes over the earnout period based on the most reliable information available. The liability is remeasured to fair value based upon the attainment against the revenue targets and changes in the fair value of earnout liabilities is presented in the consolidated statements of operations using Level 3 fair value inputs. As of January 31, 2023, the ViriCiti Earnout liability was determined to be $7.1 million, which was based on the actual achievement of the revenue target, and was subsequently paid in full on March 6, 2023 (see Note 3, Business Combination

Composition of Certain Financia

Composition of Certain Financial Statement Items	6 Months Ended
	Jul. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Composition of Certain Financial Statement Items	Composition of Certain Financial Statement Items Inventories Inventories consisted of the following: July 31, January 31, (in thousands) Raw materials $ 8,814 $ 11,509 Finished goods and components 134,766 57,221 Total Inventories $ 143,580 $ 68,730 Inventory levels are analyzed periodically and written down to their net realizable value if they have become obsolete, have a cost basis in excess of expected net realizable value or are in excess of expected demand. During the three months ended July 31, 2023, the Company recorded an impairment charge of $28.0 million, consisting of $15.0 million charge to write down the carrying value of certain inventory on hand, as well as $13.0 million charge for losses on non-cancelable purchase commitments for inventory to be received after July 31, 2023, to reduce the carrying value of certain DC fast charging products to their estimated net realizable value. The inventory impairment charge is included in the cost of revenue - networked charging systems in the condensed consolidated statements of operations. Prepaid expense and other current assets Prepaid expense and other current assets consisted of the following: July 31, January 31, (in thousands) Prepaid expense $ 57,996 $ 48,464 Other current assets 24,661 22,556 Total Prepaid Expense and Other Current Assets $ 82,657 $ 71,020 Property and Equipment, net Property and equipment, net consisted of the following: July 31, January 31, (in thousands) Furniture and fixtures $ 1,731 $ 1,244 Computers and software 7,907 7,164 Machinery and equipment 30,189 25,144 Tooling 14,828 13,782 Leasehold improvements 9,900 9,357 Owned and operated systems 26,352 24,119 Construction in progress 2,973 2,790 93,880 83,600 Less: Accumulated depreciation (51,144) (43,554) Total Property and Equipment, Net $ 42,736 $ 40,046 The following table presents the depreciation expense: Three Months Ended Six Months Ended 2023 2022 2023 2022 (in thousands) Depreciation expense 3,925 3,300 7,941 6,660 Accrued and Other Current Liabilities Accrued and other current liabilities consisted of the following: July 31, January 31, (in thousands) Accrued expenses $ 62,616 $ 46,105 Refundable customer deposits 16,276 14,551 Payroll and related expenses 18,085 21,495 Taxes payable 18,620 14,232 Other liabilities 30,128 37,100 Total Accrued and Other Current Liabilities $ 145,725 $ 133,483 Revenue Revenue consisted of the following: Three Months Ended Six Months Ended 2023 2022 2023 2022 (in thousands) United States $ 112,960 $ 84,610 $ 210,091 $ 146,925 Rest of World 37,534 23,682 70,432 43,000 Total revenue $ 150,494 $ 108,292 $ 280,523 $ 189,925 Deferred Revenue The following table shows the total deferred revenue for each period presented. July 31, January 31, (in thousands) Deferred revenue 219,842 198,610 The following table shows the revenue recognized that was included in the deferred revenue balance at the beginning of the period. Three Months Ended Six Months Ended 2023 2022 2023 2022 (in thousands) Deferred revenue recognized $ 24,418 $ 14,736 $ 50,432 $ 37,388 Remaining Performance Obligation Remaining performance obligations represents the amount of contracted future revenue not yet recognized as the amounts relate to undelivered performance obligations, including both deferred revenue and non-cancellable contracted amounts that will be invoiced and recognized as revenue in future periods. Revenue expected to be recognized from remaining performance obligations was $244.6 million as of July 31, 2023, of which 42% is expected to be recognized over the next twelve months.

Debt

Debt	6 Months Ended
	Jul. 31, 2023
Debt Disclosure [Abstract]
Debt	Debt 2027 Convertible Notes The following table presents the Company’s convertible debt outstanding: July 31, January 31, 2023 (in thousands) Gross amount $ 300,000 $ 300,000 Debt discount and issuance costs (4,461) (5,064) Carrying amount $ 295,539 $ 294,936 Estimated fair value (Level 2 Inputs) $ 227,000 $ 233,000 The following table presents the Company’s interest expense related to convertible debt: Three Months Ended Six Months Ended 2023 2022 2023 2022 (in thousands) Contractual interest expense $ 2,625 $ 2,625 $ 5,250 $ 3,500 Amortization of debt discount and issuance costs 301 303 603 362 Total interest expense $ 2,926 $ 2,928 $ 5,853 $ 3,862 In April 2022, the Company completed a private placement of $300.0 million aggregate principal amount of unsecured Convertible Senior PIK Toggle Notes (the “2027 Convertible Notes”), which will mature on April 1, 2027. The 2027 Convertible Notes were sold in a private placement in reliance on the exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”) provided by Section 4(a)(2) of the Securities Act . The net proceeds from the sale of the 2027 Convertible Notes were approximately $294.0 million after deducting initial purchaser discounts and commissions and the Company’s offering expenses. The debt discount and issuance costs, net of accumulated amortization, are reported as a direct deduction from the face amount of the 2027 Convertible Notes. The Company expects to use the net proceeds for general corporate purposes. The 2027 Convertible Notes bear interest at 3.50% per annum, to the extent paid in cash (“Cash Interest”), and 5.00% per annum, to the extent paid in kind through the issuance of additional 2027 Convertible Notes (“PIK Interest”). Interest is payable semi-annually in arrears on April 1st and October 1st of each year, beginning on October 1, 2022. The Company can elect to make any interest payment through Cash Interest, PIK Interest or any combination thereof. The 2027 Convertible Notes are convertible, based on the applicable conversion rate, into cash, shares of the Company’s Common Stock or a combination thereof, at the Company’s election. The initial conversion rate was 41.6119 shares per $1,000 principal amount of the 2027 Convertible Notes, subject to customary anti-dilution adjustment in certain circumstances, which represented an initial conversion price of approximately $24.03 per share. Prior to January 1, 2027, the 2027 Convertible Notes will be convertible at the option of the holders only upon the occurrence of specified events and during certain periods, and will be convertible on or after January 1, 2027, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2027 Convertible Notes. Holders of the 2027 Convertible Notes may convert all or a portion of their 2027 Convertible Notes prior to the close of business on January 1, 2027, only under the following circumstances: • during any calendar quarter commencing after the calendar quarter ending on September 30, 2022, if the Company’s closing Common Stock price for at least 20 trading days out of the most recent 30 consecutive trading days of the preceding calendar quarter is greater than or equal to 130% of the current conversion price of the 2027 Convertible Notes on each applicable trading day; • during the five business days period after any ten consecutive trading days in which, if the trading price per $1,000 principal amount of the 2027 Convertible Notes for each trading day of such ten consecutive trading day period is less than 98% of the product of the Company’s closing Common Stock price and the conversion rate of the 2027 Convertible Notes on each such trading day; • if the Company calls the 2027 Convertible Notes for redemption, at any time prior to the close of business on the second business day immediately preceding the redemption date; • upon the occurrence of specified corporate events, including certain distributions, the occurrence of a fundamental change or a transaction resulting in the Company’s Common Stock converting into other securities or property or assets. The 2027 Convertible Notes will be redeemable, in whole or in part, at the Company’s option at any time on or after April 21, 2025, and before the 41st scheduled trading day immediately before the maturity date. The redemption price will be equal to the aggregate principal amount of the 2027 Convertible Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. In addition, a holder may elect to convert its 2027 Convertible Notes during any such redemption period, in which case the applicable conversion rate may be increased in certain circumstances if the 2027 Convertible Notes are converted after they are called for redemption. Additionally, if the Company undergoes a fundamental change or a change in control transaction (each such term as defined in the indenture governing the 2027 Convertible Notes), subject to certain conditions, holders may require the Company to purchase for cash all or any portion of their 2027 Convertible Notes. The fundamental change repurchase price will be 100% of the capitalized principal amount of the 2027 Convertible Notes, while the change in control repurchase price will be 125% of the capitalized principal amount of the 2027 Convertible Notes to be purchased, in each case plus any accrued and unpaid interest to, but excluding, the repurchase date. The indenture governing the 2027 Convertible Notes includes a restrictive covenant that, subject to specified exceptions, limits the ability of the Company and its subsidiaries to incur secured debt in excess of $750.0 million. In addition, the indenture governing the 2027 Convertible Notes contains customary terms and covenants, including certain events of default in which case either the trustee or the holders of at least 25% of the aggregate principal amount of the outstanding 2027 Convertible Notes may declare 100% of the principal of, and accrued and unpaid interest, if any, on, all the 2027 Convertible Notes to be due and payable immediately. As of July 31, 2023, the effective interest rate on the 2027 Convertible Notes was 3.93%. Amortization of debt discount and issuance costs is reported as a component of interest expenses and is computed using the straight-line method over the term of the 2027 Convertible Notes, which approximates the effective interest method. The estimated fair value of the 2027 Convertible Notes, valued using Level 2 fair value inputs, as of July 31, 2023 and January 31, 2023 was $227.0 million and $233.0 million, respectively. 2027 Revolving Credit Facility On July 27, 2023, the Company entered into a revolving credit agreement by and among the Company, ChargePoint, Inc. (the “Borrower”), certain subsidiaries of the Borrower as guarantors (the “Subsidiary Guarantors”), JPMorgan Chase Bank, N.A., as administrative agent, and the other lenders party thereto (the “Credit Agreement”). The Credit Agreement provides for senior secured revolving credit facility in an initial aggregate principal amount of up to $150.0 million, with a maturity date of January 1, 2027 (the “2027 Revolving Credit Facility”). Pursuant to the Credit Agreement, the Borrower may from time to time arrange for one or more increases in the commitments under the 2027 Revolving Credit Facility in an aggregate principal amount not to exceed $150 million, subject to obtaining the consent of the lenders participating in any such increase. Up to $100.0 million of the 2027 Revolving Credit Facility may be used for the issuance of letters of credit. The obligations of the Borrower under the Credit Agreement are guaranteed by the Company and the Subsidiary Guarantors and secured by a first priority pledge of the equity securities of the Borrower and certain of its subsidiaries and first priority security interests in substantially all tangible and intangible personal property, including intellectual property, of the Company, the Borrower and each Subsidiary Guarantor, subject to customary exceptions and limitations. The Credit Agreement contains negative covenants that, among other things, restrict the ability of the Company, the Borrower and its subsidiaries, as applicable, to incur additional indebtedness, incur additional liens, make investments or acquisitions, make dividends, distributions, or other restricted payments, dispose of property, and enter into transactions with affiliates, in each case subject to certain dollar baskets and customary carveouts, as well as customary events of default. In addition, the Credit Agreement requires the Borrower to comply with a minimum total liquidity covenant (“Total Liquidity”) which requires the Borrower to maintain, at all times, Total Liquidity equal to the sum of cash and cash equivalents held by the Borrower and the other loan parties at controlled accounts with the initial lenders under the Credit Agreement plus the aggregate unused amount of the commitments then available to be drawn under the 2027 Revolving Credit Facility. Borrowings under the 2027 Revolving Credit Facility may be denominated in U.S. dollars, Euros, or Pound Sterling. At the Company’s option, borrowings may bear interest at a rate per annum equal to either (a) an alternate base rate (for borrowings in U.S. dollars) plus a rate per annum of 1.75%, (b) an adjusted SOFR term rate (for borrowings in U.S. dollars) plus a rate per annum of 2.75%, (c) an adjusted EURIBOR rate (for borrowings in Euros) plus a rate per annum of 2.75%, or (d) a daily simple “risk-free” rate (for borrowings in Pounds Sterling) plus a rate per annum of 2.75%. The Company will pay commitment fees on the average daily unused amount of the 2027 Revolving Credit Facility at a rate per annum of 0.40%. In addition, the Company will also pay participation fees on the average daily undrawn amount of outstanding letters of credit at a rate per annum of 2.25%. As of July 31, 2023, the Borrower had no borrowings outstanding under the 2027 Revolving Credit Facility. The Borrower also had no letters of credit outstanding under the Credit Agreement as of July 31, 2023 and, as a result, had a borrowing capacity of up to $150.0 million.

Commitment and Contingencies

Commitment and Contingencies	6 Months Ended
	Jul. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Purchase Commitments Open purchase commitments are for the purchase of goods and services related to, but not limited to, manufacturing, facilities and professional services under non-cancellable contracts. No open purchase commitments were recorded as liabilities on the condensed consolidated balance sheets as of July 31, 2023 as the Company had not yet received the related goods or services. Legal Proceedings The Company may be involved in various lawsuits, claims, and proceedings, including intellectual property, commercial, securities, and employment matters that arise in the normal course of business. The Company accrues a liability when management believes information available prior to the issuance of the condensed consolidated financial statements indicates it is probable a loss has been incurred as of the date of the condensed consolidated financial statements and the amount of loss can be reasonably estimated. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Legal costs are expensed as incurred. The Company believes it has recorded adequate provisions for any such lawsuits, claims, and proceedings and, as of July 31, 2023, the Company believes it was not reasonably possible that a material loss had been incurred in excess of the amounts recognized in the condensed consolidated financial statements. Based on its experience, the Company believes that damage amounts claimed in these matters are not meaningful indicators of potential liability. Given the inherent uncertainties of litigation, the ultimate outcome of the ongoing matters described herein cannot be predicted with certainty. While litigation is inherently unpredictable, the Company believes it has valid defenses with respect to the legal matters pending against it. Nevertheless, the Company’s results of operations, cash flows and financial condition could be materially adversely affected in a particular period by the resolution of one or more of these contingencies. Liabilities established to provide for contingencies are adjusted as further information develops, circumstances change, or contingencies are resolved; and such changes are recorded in the accompanying condensed consolidated statements of operations during the period of the change and reflected in accrued and other current liabilities on the accompanying condensed consolidated balance sheets. Guarantees and Indemnifications The Company has service level commitments to certain of its customers warranting levels of uptime reliability and performance and permitting those customers to receive credits if the Company fails to meet those levels. To date, the Company has not incurred any material costs as a result of such commitments. The Company’s arrangements generally include certain provisions for indemnifying customers against liabilities if its products or services infringe a third-party’s intellectual property rights. Additionally, the Company may be required to indemnify for claims caused by its negligence or willful misconduct. It is not possible to determine the maximum potential amount under these indemnification obligations due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. To date, the Company has not incurred any material costs as a result of such obligations and has not accrued any liabilities related to such obligations in the condensed consolidated financial statements. The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by them in any action or proceeding to which any of them are, or are threatened to be, made a party by reason of their service as a director or officer. The Company maintains director and officer insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company also may be subject to indemnification obligations by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions. Letters of Credit The Company had $30.4 million of secured letters of credit outstanding as of both July 31, 2023 and January 31, 2023. These primarily relate to support of contract manufacturer and customer agreements, and are fully collateralized by cash deposits which the Company recorded in restricted cash on its condensed consolidated balance sheets based on the term of the remaining restriction. Leases The Company leases its office facilities under non-cancelable operating leases with various lease terms. The Company also leases certain office equipment under operating lease agreements. The following table presents future payments of lease liabilities under the Company's non-cancelable operating leases as of July 31, 2023 (in thousands): (in thousands) 2024 (remaining six months) $ 3,532 2025 6,220 2026 5,016 2027 4,710 2028 4,103 Thereafter 6,252 Total undiscounted operating lease payments 29,833 Less: imputed interest (6,028) Total operating lease liabilities 23,805 Less: current portion of operating lease liabilities (4,261) Operating lease liabilities, noncurrent $ 19,544

Common Stock

Common Stock	6 Months Ended
	Jul. 31, 2023
Equity [Abstract]
Common Stock	Common Stock As of July 31, 2023 and January 31, 2023, the Company was authorized to issue 1,000,000,000 shares of Common Stock, with a par value of $0.0001 per share. There were 359,792,252 and 348,330,481 shares issued and outstanding as of July 31, 2023 and January 31, 2023, respectively. At-the-Market Offering On July 1, 2022, ChargePoint filed a registration statement on Form S-3 (File No. 333-265986) with the SEC (that was declared effective by the SEC on July 12, 2022), which permits the Company to offer up to $1.0 billion of Common Stock, preferred stock, debt securities, warrants and rights in one or more offerings and in any combination, including in units from time to time (the “Shelf Registration Statement”). As part of the Shelf Registration Statement, ChargePoint filed a prospectus supplement registering for sale from time to time up to $500.0 million of Common Stock pursuant to a sales agreement (the “ATM Facility”). During the three months ended July 31, 2023, the Company sold a total of 4,076,072 shares of its Common Stock pursuant to the ATM Facility at the prevailing market prices for total proceeds of $37.3 million, net of $0.4 million of issuance costs. During the six months ended July 31, 2023, the Company sold a total of 5,985,100 shares of its Common Stock pursuant to the ATM Facility at the prevailing market prices for total proceeds of $54.8 million, net of $0.6 million of issuance costs. Common Stock Warrants Legacy ChargePoint had outstanding warrants to purchase shares of Legacy ChargePoint common stock (collectively, “Legacy Warrants”), which now represent warrants to purchase Common Stock. As of July 31, 2023, there were 34,499,436 Legacy Warrants outstanding, which are classified as equity. There was no Legacy Warrants activity during the three and six months ended July 31, 2023. There was no Legacy Warrants activity during the three months ended July 31, 2022. During the six months ended July 31, 2022, 14,568 Legacy Warrants were exercised resulting in the issuance of 13,223 shares of Common Stock. There were no cash proceeds received for the exercise of Legacy Warrants. Activity of Legacy Warrants is set forth below: Legacy Warrants Outstanding as of January 31, 2023 34,499,436 Warrants exercised — Outstanding as of July 31, 2023 34,499,436 Private Placement Warrants The Private Placement Warrants were initially recognized as a liability, and remeasured to fair value as of any respective exercise dates. On February 21, 2022, the Company redeemed the remaining Private Placement Warrants for 0.355 shares of Common Stock per warrant, resulting in the Company recording no gain or loss and an immaterial loss for the three and six months ended July 31, 2022, respectively. No Private Placement Warrants have been outstanding since April 30, 2022.

Stock Warrants

Stock Warrants	6 Months Ended
	Jul. 31, 2023
Equity [Abstract]
Stock Warrants	Common Stock As of July 31, 2023 and January 31, 2023, the Company was authorized to issue 1,000,000,000 shares of Common Stock, with a par value of $0.0001 per share. There were 359,792,252 and 348,330,481 shares issued and outstanding as of July 31, 2023 and January 31, 2023, respectively. At-the-Market Offering On July 1, 2022, ChargePoint filed a registration statement on Form S-3 (File No. 333-265986) with the SEC (that was declared effective by the SEC on July 12, 2022), which permits the Company to offer up to $1.0 billion of Common Stock, preferred stock, debt securities, warrants and rights in one or more offerings and in any combination, including in units from time to time (the “Shelf Registration Statement”). As part of the Shelf Registration Statement, ChargePoint filed a prospectus supplement registering for sale from time to time up to $500.0 million of Common Stock pursuant to a sales agreement (the “ATM Facility”). During the three months ended July 31, 2023, the Company sold a total of 4,076,072 shares of its Common Stock pursuant to the ATM Facility at the prevailing market prices for total proceeds of $37.3 million, net of $0.4 million of issuance costs. During the six months ended July 31, 2023, the Company sold a total of 5,985,100 shares of its Common Stock pursuant to the ATM Facility at the prevailing market prices for total proceeds of $54.8 million, net of $0.6 million of issuance costs. Common Stock Warrants Legacy ChargePoint had outstanding warrants to purchase shares of Legacy ChargePoint common stock (collectively, “Legacy Warrants”), which now represent warrants to purchase Common Stock. As of July 31, 2023, there were 34,499,436 Legacy Warrants outstanding, which are classified as equity. There was no Legacy Warrants activity during the three and six months ended July 31, 2023. There was no Legacy Warrants activity during the three months ended July 31, 2022. During the six months ended July 31, 2022, 14,568 Legacy Warrants were exercised resulting in the issuance of 13,223 shares of Common Stock. There were no cash proceeds received for the exercise of Legacy Warrants. Activity of Legacy Warrants is set forth below: Legacy Warrants Outstanding as of January 31, 2023 34,499,436 Warrants exercised — Outstanding as of July 31, 2023 34,499,436 Private Placement Warrants The Private Placement Warrants were initially recognized as a liability, and remeasured to fair value as of any respective exercise dates. On February 21, 2022, the Company redeemed the remaining Private Placement Warrants for 0.355 shares of Common Stock per warrant, resulting in the Company recording no gain or loss and an immaterial loss for the three and six months ended July 31, 2022, respectively. No Private Placement Warrants have been outstanding since April 30, 2022.

Equity Plans and Stock-based Co

Equity Plans and Stock-based Compensation	6 Months Ended
	Jul. 31, 2023
Share-Based Payment Arrangement [Abstract]
Equity Plans and Stock-based Compensation	Equity Plans and Stock-based Compensation The following sets forth the total stock-based compensation expense for employee equity plans included in the Company’s condensed consolidated statements of operations: Three Months Ended Six Months Ended 2023 2022 2023 2022 (in thousands) Cost of revenue $ 1,938 $ 1,341 $ 2,933 $ 2,126 Research and development 15,847 11,420 25,353 17,398 Sales and marketing 6,757 5,285 10,926 7,831 General and administrative 10,557 8,373 19,851 14,591 Total stock-based compensation expense $ 35,099 $ 26,419 $ 59,063 $ 41,946 As of July 31, 2023, the Company had unrecognized stock-based compensation expense related to stock options, RSUs and PRSUs (as defined below), and 2021 ESPP (as defined below) of $228.5 million, which is expected to be recognized over a weighted-average period of 2.97 years. 2021 Employee Stock Purchase Plan The 2021 Employee Stock Purchase Plan (“2021 ESPP”) permits participants to purchase shares of the Company’s Common Stock at a discounted price through payroll deductions. As of July 31, 2023, 13,842,252 shares of Common Stock were available under the 2021 ESPP. 2021 Equity Incentive Plan The 2021 Equity Incentive Plan (“2021 EIP”) allows the Company to grant stock options, stock appreciation rights, restricted stock units (“RSUs”), performance restricted stock units (“PRSUs”), and certain other awards. As of July 31, 2023, 44,405,539 shares of Common Stock were available under the 2021 EIP. There were no options granted for the three and six months ended July 31, 2023. Restricted Stock Units A summary of RSUs outstanding under the 2021 EIP as of July 31, 2023 and changes during the fiscal year-to-date period then ended is presented in the following table: Number of Shares Weighted Average Grant Date Fair Value per Share Outstanding as of January 31, 2023 12,935,413 $ 15.02 RSU granted 13,600,840 $ 8.68 RSU vested (2,813,610) $ 14.37 RSU forfeited (959,444) $ 13.97 Outstanding as of July 31, 2023 22,763,199 $ 11.36 Performance Restricted Stock Units A summary of PRSUs outstanding under the 2021 EIP as of July 31, 2023 and changes during the fiscal year-to-date period then ended is presented in the following table: Number of Shares Weighted Average Grant Date Fair Value per Share Outstanding as of January 31, 2023 2,147,366 $ 10.83 PRSUs granted 60,892 $ 8.21 PRSU forfeited (143,266) $ 10.47 Outstanding as of July 31, 2023 2,064,992 $ 10.77 2017 Plan and 2007 Plan In fiscal year 2022, the Company terminated its 2017 Stock Option Plan (the “2017 Plan”) and 2007 Stock Option Plan (the “2007 Plan”). A summary of options outstanding under the 2017 Plan and 2007 Plan as of July 31, 2023 and changes during the fiscal year-to-date period then ended is presented in the following table: Number of Stock Option Awards Weighted Average Exercise Price Weighted Average Remaining Contractual term (in years) Aggregate Intrinsic Value (in thousands) Outstanding as of January 31, 2023 17,600,524 $ 0.70 5.6 $ 201,352 Options exercised (2,103,163) $ 0.64 Options cancelled (130,985) $ 0.77 Outstanding as of July 31, 2023 15,366,376 $ 0.71 5.4 $ 122,193 Options vested and expected to vest as of July 31, 2023 15,363,337 $ 0.71 5.4 $ 122,169 Exercisable as of July 31, 2023 13,120,974 $ 0.70 5.1 $ 104,454

Income Taxes

Income Taxes	6 Months Ended
	Jul. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesThe income tax provision for interim periods is determined using an estimate of the Company’s annual effective tax rate as adjusted for discrete items arising in that quarter. The effective income tax rate was (0.7)% and 0.4% for the three months ended July 31, 2023 and 2022, respectively. The effective income tax rate was (0.2)% and 1.2% for the six months ended July 31, 2023 and 2022, respectively. The effective tax rate differs from the U.S. statutory rate primarily due to the full valuation allowances on the Company’s net domestic deferred tax assets as it is more likely than not that all of the deferred tax assets will not be realized.

Basic and Diluted Net Loss per

Basic and Diluted Net Loss per Share	6 Months Ended
	Jul. 31, 2023
Earnings Per Share [Abstract]
Basic and Diluted Net Loss per Share	Basic and Diluted Net Loss per Share The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the three and six months ended July 31, 2023 and 2022: Three Months Ended Six Months Ended 2023 2022 2023 2022 (in thousands, except share and per share data) Numerator: Net loss $ (125,255) $ (92,700) $ (204,643) $ (181,966) Denominator: Weighted average common shares outstanding 355,893,921 336,911,941 353,031,968 335,845,756 Less: Weighted average unvested restricted shares and shares subject to repurchase (17,114) (98,386) (23,495) (108,984) Weighted average shares outstanding - Basic and Diluted 355,876,807 336,813,555 353,008,473 335,736,772 Net loss per share - Basic and Diluted $ (0.35) $ (0.28) $ (0.58) $ (0.54) The potential shares of Common Stock that were excluded from the computation of diluted net loss per share attributable to common stockholders at each period end because including them would have had an antidilutive effect were as follows: July 31, July 31, 2027 Convertible Notes (on an as-converted basis) 12,483,569 12,483,569 Options to purchase common stock 15,366,376 19,280,776 Restricted stock units 22,763,199 13,377,719 Unvested early exercised common stock options 12,178 89,877 Common stock warrants 34,499,436 35,524,021 Employee stock purchase plan 2,739,885 1,739,928 Total potentially dilutive common share equivalents 87,864,643 82,495,890 PRSUs granted were excluded from the above table because the respective stock price targets have not been met as of July 31, 2023.

Subsequent Events

Subsequent Events	6 Months Ended
	Jul. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events On September 6, 2023, the Company announced the reorganizing of its operations including a reduction of the Company's current global workforce by approximately 10% (the “Reorganization”). The Reorganization is expected to lead to approximately $8.0 million in charges, consisting primarily of severance benefits and facility-related expenses. The Company expects that most of these charges will be cash expenditures and that it will recognize these charges primarily during its fiscal third quarter. The estimates of the charges and expenditures that the Company expects to incur in connection with the Reorganization, and the timing thereof, are subject to a number of assumptions, including local law requirements in various jurisdictions, and actual amounts may differ materially from estimates. In addition, the Company may incur other charges or cash expenditures not currently contemplated due to unanticipated events that may occur, including in connection with the implementation of the Reorganization.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jul. 31, 2023	Apr. 30, 2023	Jul. 31, 2022	Apr. 30, 2022	Jul. 31, 2023	Jul. 31, 2022
Pay vs Performance Disclosure
Net loss	$ (125,255)	$ (79,388)	$ (92,700)	$ (89,266)	$ (204,643)	$ (181,966)

Insider Trading Arrangements

Insider Trading Arrangements - shares		3 Months Ended
	Jun. 14, 2023	Jul. 31, 2023
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted		false
Rule 10b5-1 Arrangement Terminated		false
Non-Rule 10b5-1 Arrangement Terminated		false
Ekta Singh-Bushell [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On June 14, 2023, Ekta Singh-Bushell, a director of the Company, adopted a Rule 10b5-1 trading plan (the “Singh-Bushell Trading Plan”) that is intended to satisfy the affirmative defense conditions of Securities Exchange Act of 1934, as amended Rule 10b5-1(c). The Singh-Bushell Trading Plan has a term of 22 months and provides for the sale of up to 8,848 shares of the Company’s common stock.
Name	Ekta Singh-Bushell
Rule 10b5-1 Arrangement Adopted		true
Adoption Date	June 14, 2023
Aggregate Available		8,848

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of PresentationThe condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reporting. The Company’s condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations.
Reverse Recapitalization	Reverse Recapitalization On February 26, 2021, Lightning Merger Sub Inc., a wholly-owned subsidiary of Switchback Energy Acquisition Corporation (“Switchback”), merged with ChargePoint, Inc. (“Legacy ChargePoint”), with Legacy ChargePoint surviving as a wholly-owned subsidiary of Switchback (the “Merger”). As a result of the Merger, Switchback was renamed “ChargePoint Holdings, Inc.” Immediately prior to the closing of the Merger (the “Closing”), Legacy ChargePoint’s outstanding series of redeemable convertible preferred stock were converted to Legacy ChargePoint common stock, which then converted to the Company’s common stock (“Common Stock”). The Merger is accounted for as a reverse capitalization in accordance with U.S. GAAP.
Use of Estimates	Use of Estimates The preparation of the accompanying condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers, the estimated expected benefit period for deferred contract acquisition costs, allowances for expected credit losses, inventory reserves, loss on purchase commitment, the useful lives of long-lived assets, the determination of the incremental borrowing rate used for operating lease liabilities, valuation of acquired goodwill and intangible assets, and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.
Concentration of Credit Risk and Other Risks and Uncertainties	Concentration of Credit Risk and Other Risks and Uncertainties Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are held in domestic and foreign cash accounts across large, creditworthy financial institutions. The Company has not experienced any losses on its deposits of cash and cash equivalents through deposits with federally insured commercial banks and at times cash deposit balances may be in excess of federal insurance limits. Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition.
Segment Reporting	Segment Reporting Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief decision maker (“CODM”). The Company operates as one operating segment because its Chief Executive Officer, as the Company’s CODM, reviews its financial information on a consolidated basis for purposes of making decisions regarding allocating resources and assessing performance. The Company has no segment managers who are held accountable by the CODM for operations, operating results, and planning for levels of components below the consolidated unit level.
Cash, Cash Equivalents, and Restricted Cash	Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments with an original maturity of three months or less, when purchased, to be cash equivalents. Cash equivalents may be invested in money market funds. Cash and cash equivalents are carried at cost, which approximates their fair value. Restricted cash relates to cash deposits restricted under letters of credit issued in support of customer and contract manufacturer agreements.
Short-Term Investments	The Company's portfolio of marketable debt securities is comprised solely of U.S. government securities with maturities of more than three months, but less than one year. The Company classifies these as available-for-sale at purchase date and will reevaluate such designation at each period end date. The Company may sell these marketable debt securities prior to their stated maturities depending upon changing liquidity requirements. These debt securities are classified as current assets in the condensed consolidated balance sheet and recorded at fair value, with unrealized gains or losses included in accumulated other comprehensive income (loss) and as a component of the condensed consolidated statements of comprehensive loss. Gains and losses are recognized when realized. Gains and losses are determined using the specific identification method and are reported in other income (expense), net in the condensed consolidated statements of operations. For available-for-sale debt securities in an unrealized loss position, the Company first assesses whether it intends to sell the security or it is more likely than not that the Company will be required to sell the security before the recovery of its entire amortized cost basis. If either of these criteria is met, the security’s amortized cost basis is written down to fair value through other income (expense), net in the consolidated statements of operations. If neither of these criteria is met, the Company evaluates whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. Credit related unrealized losses are recognized as an allowance for expected credit losses of available-for-sale debt securities on the consolidated balance sheets with a corresponding charge in other income (expense), net in the consolidated statements of operations. Non-credit related unrealized losses are included in accumulated other comprehensive income (loss).
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets and liabilities measured at fair value are classified into the following categories based on the inputs used to measure fair value: • (Level 1) — Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date; • (Level 2) — Inputs other than quoted prices in active markets that are observable for the asset or liability, either directly or indirectly; and • (Level 3) — Inputs that are unobservable for the asset or liability. The Company classifies financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the asset or liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. There were no transfers between levels during the periods presented. The Company had no material non-financial assets valued on a non-recurring basis that resulted in an impairment in any period presented. The carrying values of the Company’s cash equivalents, accounts receivable, net, accounts payable, and accrued and other current liabilities approximate fair value based on the highly liquid, short-term nature of these instruments.
Reclassifications of Prior Period Presentation	Reclassifications of Prior Period Presentation Certain prior period amounts have been reclassified for consistency with the current year presentation. For the six months ended July 31, 2022, “operating lease liabilities,” “accounts payable,” and “accrued and other liabilities” were combined and presented as a single line item captioned “accounts payable, operating lease liabilities and accrued and other liabilities” within the net cash used in operating activities section of the condensed consolidated statements of cash flows instead of being separately stated as in prior period presentations.
Accounting Pronouncements	Accounting Pronouncements Recently Issued Accounting Standards Adopted In March 2022, the Financial Accounting Standards Board (“FASB”) issued ASU 2022-02, “ Financial Instruments—Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures,” which addresses areas identified by the FASB as part of its post-implementation review of ASU 2016-13, “ Financial Instruments--Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”) that introduced the current expected credit losses (“CECL”) model. The new guidance eliminates the accounting guidance for troubled debt restructurings by creditors that have already adopted the CECL model and enhances the disclosure requirements for loan refinancings and restructurings made with borrowers experiencing financial difficulty. In addition, the new guidance requires a public business entity to disclose current-period gross write-offs for financing receivables and net investment in leases by year of origination. The guidance is effective for public business entities that have adopted ASU 2016-13 for fiscal years beginning after December 31, 2022, including interim periods within those fiscal years. The Company adopted ASU 2022-02 on February 1, 2023 and elected to apply the amendments prospectively to all transactions within the scope of the amendment that are reflected in the financial statements at the date of adoption. The adoption did not have a material effect on the condensed consolidated financial statements and related disclosures.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jul. 31, 2023
Accounting Policies [Abstract]
Schedule of Cash and Cash Equivalents	The reconciliation of cash, cash equivalents, and restricted cash to amounts presented in the consolidated condensed statements of cash flows was as follows: July 31, January 31, (in thousands) Cash and cash equivalents $ 233,499 $ 264,162 Restricted cash 30,400 30,400 Total cash, cash equivalents, and restricted cash $ 263,899 $ 294,562
Restrictions on Cash and Cash Equivalents	The reconciliation of cash, cash equivalents, and restricted cash to amounts presented in the consolidated condensed statements of cash flows was as follows: July 31, January 31, (in thousands) Cash and cash equivalents $ 233,499 $ 264,162 Restricted cash 30,400 30,400 Total cash, cash equivalents, and restricted cash $ 263,899 $ 294,562
Schedule of Short-Term Investments	As of January 31, 2023, short-term investments consisted of the following: January 31, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value (in thousands) U.S. Treasury Securities $ 105,415 $ — $ (449) $ 104,966

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
	Jul. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table summarizes the changes in carrying amounts of goodwill (in thousands): Balance as of January 31, 2023 $ 213,716 Foreign exchange fluctuations 2,899 Balance as of July 31, 2023 $ 216,615
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	The following table presents the details of intangible assets: July 31, 2023 Cost (1) Accumulated Amortization (1) Net (1) Useful Life (amounts in thousands, useful lives in years) Customer relationships $ 92,153 $ (17,017) $ 75,136 10 Developed technology 18,584 (5,796) 12,788 6 $ 110,737 $ (22,813) $ 87,924 _______________ (1) Values are translated into U.S. Dollars at period-end foreign exchange rates. January 31, 2023 Cost (1) Accumulated Amortization (1) Net (1) Useful Life (amounts in thousands, useful lives in years) Customer relationships $ 90,738 $ (12,223) $ 78,515 10 Developed technology 18,355 (4,197) 14,158 6 $ 109,093 $ (16,420) $ 92,673 _______________ (1) Values are translated into U.S. Dollars at period-end foreign exchange rates.
Schedule of Finite-Lived Intangible Assets Amortization Expense	The following table presents the amortization expense related to intangible assets: Three Months Ended Six Months Ended 2023 2022 2023 2022 (in thousands) Amortization expense $ 3,039 $ 2,956 $ 6,077 $ 5,816

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jul. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows: Fair Value Measured as of July 31, 2023 Level 1 Level 2 Level 3 Total (in thousands) Assets Money market funds $ 2,343 $ — $ — $ 2,343 Total financial assets $ 2,343 $ — $ — $ 2,343 Fair Value Measured as of January 31, 2023 Level 1 Level 2 Level 3 Total (in thousands) Assets Money market funds $ 133,979 $ — $ — $ 133,979 U.S. Treasury securities — 104,966 — 104,966 Total financial assets $ 133,979 $ 104,966 $ — $ 238,945
Schedule of Changes in the Fair Value of the Company's Level 3 Financial Instruments	The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments for the six months ended July 31, 2022: Private placement warrant liability ViriCiti Earnout liability (in thousands) Fair value as of January 31, 2022 $ (25) $ (5,993) Change in fair value included in other income (expense), net (23) — Effect of foreign currency translation — 505 Reclassification of warrants to stockholders’ equity (deficit) due to exercise 48 — Fair value as of July 31, 2022 $ — $ (5,488)

Composition of Certain Financ_2

Composition of Certain Financial Statement Items (Tables)	6 Months Ended
	Jul. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Inventories	Inventories consisted of the following: July 31, January 31, (in thousands) Raw materials $ 8,814 $ 11,509 Finished goods and components 134,766 57,221 Total Inventories $ 143,580 $ 68,730
Schedule of Other Current Assets	Prepaid expense and other current assets consisted of the following: July 31, January 31, (in thousands) Prepaid expense $ 57,996 $ 48,464 Other current assets 24,661 22,556 Total Prepaid Expense and Other Current Assets $ 82,657 $ 71,020
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following: July 31, January 31, (in thousands) Furniture and fixtures $ 1,731 $ 1,244 Computers and software 7,907 7,164 Machinery and equipment 30,189 25,144 Tooling 14,828 13,782 Leasehold improvements 9,900 9,357 Owned and operated systems 26,352 24,119 Construction in progress 2,973 2,790 93,880 83,600 Less: Accumulated depreciation (51,144) (43,554) Total Property and Equipment, Net $ 42,736 $ 40,046 The following table presents the depreciation expense: Three Months Ended Six Months Ended 2023 2022 2023 2022 (in thousands) Depreciation expense 3,925 3,300 7,941 6,660
Schedule of Accrued and Other Current Liabilities	Accrued and other current liabilities consisted of the following: July 31, January 31, (in thousands) Accrued expenses $ 62,616 $ 46,105 Refundable customer deposits 16,276 14,551 Payroll and related expenses 18,085 21,495 Taxes payable 18,620 14,232 Other liabilities 30,128 37,100 Total Accrued and Other Current Liabilities $ 145,725 $ 133,483
Schedule of Revenue	Revenue consisted of the following: Three Months Ended Six Months Ended 2023 2022 2023 2022 (in thousands) United States $ 112,960 $ 84,610 $ 210,091 $ 146,925 Rest of World 37,534 23,682 70,432 43,000 Total revenue $ 150,494 $ 108,292 $ 280,523 $ 189,925
Disaggregation of Revenue	The following table shows the total deferred revenue for each period presented. July 31, January 31, (in thousands) Deferred revenue 219,842 198,610 The following table shows the revenue recognized that was included in the deferred revenue balance at the beginning of the period. Three Months Ended Six Months Ended 2023 2022 2023 2022 (in thousands) Deferred revenue recognized $ 24,418 $ 14,736 $ 50,432 $ 37,388

Debt (Tables)

Debt (Tables)	6 Months Ended
	Jul. 31, 2023
Debt Disclosure [Abstract]
Schedule of Convertible Debt	The following table presents the Company’s convertible debt outstanding: July 31, January 31, 2023 (in thousands) Gross amount $ 300,000 $ 300,000 Debt discount and issuance costs (4,461) (5,064) Carrying amount $ 295,539 $ 294,936 Estimated fair value (Level 2 Inputs) $ 227,000 $ 233,000
Schedule of Interest Expense	The following table presents the Company’s interest expense related to convertible debt: Three Months Ended Six Months Ended 2023 2022 2023 2022 (in thousands) Contractual interest expense $ 2,625 $ 2,625 $ 5,250 $ 3,500 Amortization of debt discount and issuance costs 301 303 603 362 Total interest expense $ 2,926 $ 2,928 $ 5,853 $ 3,862

Commitment and Contingencies (T

Commitment and Contingencies (Tables)	6 Months Ended
	Jul. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Lease Payments Under All Non-cancellable Operating Leases	The following table presents future payments of lease liabilities under the Company's non-cancelable operating leases as of July 31, 2023 (in thousands): (in thousands) 2024 (remaining six months) $ 3,532 2025 6,220 2026 5,016 2027 4,710 2028 4,103 Thereafter 6,252 Total undiscounted operating lease payments 29,833 Less: imputed interest (6,028) Total operating lease liabilities 23,805 Less: current portion of operating lease liabilities (4,261) Operating lease liabilities, noncurrent $ 19,544

Stock Warrants (Tables)

Stock Warrants (Tables)	6 Months Ended
	Jul. 31, 2023
Equity [Abstract]
Schedule of Common Stock Warrants	Activity of Legacy Warrants is set forth below: Legacy Warrants Outstanding as of January 31, 2023 34,499,436 Warrants exercised — Outstanding as of July 31, 2023 34,499,436

Equity Plans and Stock-based _2

Equity Plans and Stock-based Compensation (Tables)	6 Months Ended
	Jul. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Stock-based Compensation Expense	The following sets forth the total stock-based compensation expense for employee equity plans included in the Company’s condensed consolidated statements of operations: Three Months Ended Six Months Ended 2023 2022 2023 2022 (in thousands) Cost of revenue $ 1,938 $ 1,341 $ 2,933 $ 2,126 Research and development 15,847 11,420 25,353 17,398 Sales and marketing 6,757 5,285 10,926 7,831 General and administrative 10,557 8,373 19,851 14,591 Total stock-based compensation expense $ 35,099 $ 26,419 $ 59,063 $ 41,946
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity	A summary of RSUs outstanding under the 2021 EIP as of July 31, 2023 and changes during the fiscal year-to-date period then ended is presented in the following table: Number of Shares Weighted Average Grant Date Fair Value per Share Outstanding as of January 31, 2023 12,935,413 $ 15.02 RSU granted 13,600,840 $ 8.68 RSU vested (2,813,610) $ 14.37 RSU forfeited (959,444) $ 13.97 Outstanding as of July 31, 2023 22,763,199 $ 11.36 A summary of PRSUs outstanding under the 2021 EIP as of July 31, 2023 and changes during the fiscal year-to-date period then ended is presented in the following table: Number of Shares Weighted Average Grant Date Fair Value per Share Outstanding as of January 31, 2023 2,147,366 $ 10.83 PRSUs granted 60,892 $ 8.21 PRSU forfeited (143,266) $ 10.47 Outstanding as of July 31, 2023 2,064,992 $ 10.77
Share-based Payment Arrangement, Option, Activity	A summary of options outstanding under the 2017 Plan and 2007 Plan as of July 31, 2023 and changes during the fiscal year-to-date period then ended is presented in the following table: Number of Stock Option Awards Weighted Average Exercise Price Weighted Average Remaining Contractual term (in years) Aggregate Intrinsic Value (in thousands) Outstanding as of January 31, 2023 17,600,524 $ 0.70 5.6 $ 201,352 Options exercised (2,103,163) $ 0.64 Options cancelled (130,985) $ 0.77 Outstanding as of July 31, 2023 15,366,376 $ 0.71 5.4 $ 122,193 Options vested and expected to vest as of July 31, 2023 15,363,337 $ 0.71 5.4 $ 122,169 Exercisable as of July 31, 2023 13,120,974 $ 0.70 5.1 $ 104,454

Basic and Diluted Net Loss pe_2

Basic and Diluted Net Loss per Share (Tables)	6 Months Ended
	Jul. 31, 2023
Earnings Per Share [Abstract]
Schedule of Loss Per Share Attributable to Common Stockholders, Basic and Diluted	The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the three and six months ended July 31, 2023 and 2022: Three Months Ended Six Months Ended 2023 2022 2023 2022 (in thousands, except share and per share data) Numerator: Net loss $ (125,255) $ (92,700) $ (204,643) $ (181,966) Denominator: Weighted average common shares outstanding 355,893,921 336,911,941 353,031,968 335,845,756 Less: Weighted average unvested restricted shares and shares subject to repurchase (17,114) (98,386) (23,495) (108,984) Weighted average shares outstanding - Basic and Diluted 355,876,807 336,813,555 353,008,473 335,736,772 Net loss per share - Basic and Diluted $ (0.35) $ (0.28) $ (0.58) $ (0.54)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The potential shares of Common Stock that were excluded from the computation of diluted net loss per share attributable to common stockholders at each period end because including them would have had an antidilutive effect were as follows: July 31, July 31, 2027 Convertible Notes (on an as-converted basis) 12,483,569 12,483,569 Options to purchase common stock 15,366,376 19,280,776 Restricted stock units 22,763,199 13,377,719 Unvested early exercised common stock options 12,178 89,877 Common stock warrants 34,499,436 35,524,021 Employee stock purchase plan 2,739,885 1,739,928 Total potentially dilutive common share equivalents 87,864,643 82,495,890

Description of Business and B_2

Description of Business and Basis of Presentation (Details) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ 1,361,406		$ 1,156,763
Cash, cash equivalents and restricted cash	263,900
Net cash used in operations	$ 190,602	$ 133,672

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Concentration of Credit Risk (Details)	6 Months Ended	12 Months Ended
	Jul. 31, 2022	Jan. 31, 2023
Accounts Receivable | Customer Concentration Risk | Largest Customer
Concentration Risk [Line Items]
Concentration risk, percentage	15%	10%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Segment Reporting (Details)	6 Months Ended
	Jul. 31, 2023 segment
Accounting Policies [Abstract]
Number of operating segments	1

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023	Jul. 31, 2022	Jan. 31, 2022
Accounting Policies [Abstract]
Cash and cash equivalents	$ 233,499	$ 264,162
Restricted cash	30,400	30,400
Total cash, cash equivalents, and restricted cash	$ 263,899	$ 294,562	$ 188,062	$ 315,635

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Investments (Details) - USD ($)	3 Months Ended
	Apr. 30, 2023	Jul. 31, 2023	Jan. 31, 2023
Summary of Investment Holdings [Line Items]
Fair Value		$ 0	$ 104,966,000
Accrued interest receivable			500,000
U.S. Treasury securities
Summary of Investment Holdings [Line Items]
Amortized Cost			105,415,000
Gross Unrealized Gains	$ 0
Gross Unrealized Losses	$ (449,000)
Fair Value			$ 104,966,000

Business Combinations (Details)

Business Combinations (Details) - USD ($) $ / shares in Units, $ in Millions	Jan. 31, 2023	Feb. 03, 2022	Oct. 06, 2021	Aug. 11, 2021
ViriCiti
Business Acquisition [Line Items]
Cash paid for acquisition				$ 79.4
Earnout contingent consideration	$ 7.1
HTB
Business Acquisition [Line Items]
Cash paid for acquisition		$ 2.8	$ 132.9
Consideration transferred			235
Value of equity purchased			$ 102.1
Equity transferred (in shares)			5,695,176
Equity transferred (in USD per share)			$ 17.92
Shares held in escrow (in shares)			885,692
Value of shares in escrow			$ 15.9
Indemnity claim period (in months)			18 months

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of Goodwill (Details) $ in Thousands	6 Months Ended
	Jul. 31, 2023 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Beginning balance	$ 213,716
Foreign exchange fluctuations	2,899
Ending balance	$ 216,615

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill impairment loss	$ 0	$ 0	$ 0	$ 0

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Business Acquisition [Line Items]
Cost	$ 110,737	$ 109,093
Accumulated amortization	(22,813)	(16,420)
Intangible assets, net	87,924	92,673
Customer relationships
Business Acquisition [Line Items]
Cost	92,153	90,738
Accumulated amortization	(17,017)	(12,223)
Intangible assets, net	$ 75,136	$ 78,515
Useful life (in years)	10 years	10 years
Developed technology
Business Acquisition [Line Items]
Cost	$ 18,584	$ 18,355
Accumulated amortization	(5,796)	(4,197)
Intangible assets, net	$ 12,788	$ 14,158
Useful life (in years)	6 years	6 years

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Schedule Of Finite-Lived Intangible Assets Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 3,039	$ 2,956	$ 6,077	$ 5,816

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)	Jul. 31, 2023	Jan. 31, 2023
Assets
Short-term investments	$ 0	$ 104,966,000
U.S. Treasury securities
Assets
Short-term investments		104,966,000
Fair Value, Recurring
Assets
Total financial assets	2,343,000	238,945,000
Fair Value, Recurring | U.S. Treasury securities
Assets
Short-term investments		104,966,000
Fair Value, Recurring | Money market funds
Assets
Short-term investments	2,343,000	133,979,000
Fair Value, Recurring | Level 1
Assets
Total financial assets	2,343,000	133,979,000
Fair Value, Recurring | Level 1 | U.S. Treasury securities
Assets
Short-term investments		0
Fair Value, Recurring | Level 1 | Money market funds
Assets
Short-term investments	2,343,000	133,979,000
Fair Value, Recurring | Level 2
Assets
Total financial assets	0	104,966,000
Fair Value, Recurring | Level 2 | U.S. Treasury securities
Assets
Short-term investments		104,966,000
Fair Value, Recurring | Level 2 | Money market funds
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 3
Assets
Total financial assets	0	0
Fair Value, Recurring | Level 3 | U.S. Treasury securities
Assets
Short-term investments		0
Fair Value, Recurring | Level 3 | Money market funds
Assets
Short-term investments	$ 0	$ 0

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jul. 31, 2023	Jan. 31, 2023	Feb. 21, 2022
Fair Value Disclosures [Abstract]
Unrealized gains or (losses)	$ 0	$ 0
Short-term investments	$ 0	104,966,000
Private Placement Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Warrant per common share (in dollars per share)			$ 0.355
Warrants outstanding (in shares)	0
ViriCiti
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Earn-out contingent consideration		$ 7,100,000

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Changes in the Fair Value of the Company's Level 3 Financial Instruments (Details) $ in Thousands	6 Months Ended
	Jul. 31, 2022 USD ($)
Private placement warrant liability
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ (25)
Change in fair value included in other income (expense), net	(23)
Effect of foreign currency translation	0
Reclassification of warrants to stockholders’ equity (deficit) due to exercise	48
Ending balance	0
ViriCiti Earnout liability
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	(5,993)
Change in fair value included in other income (expense), net	0
Effect of foreign currency translation	505
Reclassification of warrants to stockholders’ equity (deficit) due to exercise	0
Ending balance	$ (5,488)

Composition of Certain Financ_3

Composition of Certain Financial Statement Items - Schedule of Inventories (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Raw materials	$ 8,814	$ 11,509
Finished goods and components	134,766	57,221
Total Inventories	$ 143,580	$ 68,730

Composition of Certain Financ_4

Composition of Certain Financial Statement Items - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jul. 31, 2023	Jul. 31, 2023	Jul. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Impairment	$ 28,000	$ 28,000	$ 0
Inventory impairment	15,000
Loss on purchase commitments	$ 13,000

Composition of Certain Financ_5

Composition of Certain Financial Statement Items - Schedule of Other Current Assets (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid expense	$ 57,996	$ 48,464
Other current assets	24,661	22,556
Total Prepaid Expense and Other Current Assets	$ 82,657	$ 71,020

Composition of Certain Financ_6

Composition of Certain Financial Statement Items - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Property, Plant and Equipment [Line Items]
Property and equipment	$ 93,880	$ 83,600
Less: Accumulated depreciation	(51,144)	(43,554)
Total Property and Equipment, Net	42,736	40,046
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment	1,731	1,244
Computers and software
Property, Plant and Equipment [Line Items]
Property and equipment	7,907	7,164
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property and equipment	30,189	25,144
Tooling
Property, Plant and Equipment [Line Items]
Property and equipment	14,828	13,782
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment	9,900	9,357
Owned and operated systems
Property, Plant and Equipment [Line Items]
Property and equipment	26,352	24,119
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment	$ 2,973	$ 2,790

Composition of Certain Financ_7

Composition of Certain Financial Statement Items - Schedule of Depreciation Expenses (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Depreciation expense	$ 3,925	$ 3,300	$ 7,941	$ 6,660

Composition of Certain Financ_8

Composition of Certain Financial Statement Items - Schedule of Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued expenses	$ 62,616	$ 46,105
Refundable customer deposits	16,276	14,551
Payroll and related expenses	18,085	21,495
Taxes payable	18,620	14,232
Other liabilities	30,128	37,100
Total Accrued and Other Current Liabilities	$ 145,725	$ 133,483

Composition of Certain Financ_9

Composition of Certain Financial Statement Items - Schedule of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Disaggregation of Revenue [Line Items]
Total revenue	$ 150,494	$ 108,292	$ 280,523	$ 189,925
United States
Disaggregation of Revenue [Line Items]
Total revenue	112,960	84,610	210,091	146,925
Rest of World
Disaggregation of Revenue [Line Items]
Total revenue	$ 37,534	$ 23,682	$ 70,432	$ 43,000

Composition of Certain Finan_10

Composition of Certain Financial Statement Items - Deferred Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Deferred revenue	$ 219,842		$ 219,842		$ 198,610
Deferred revenue recognized	$ 24,418	$ 14,736	$ 50,432	$ 37,388

Composition of Certain Finan_11

Composition of Certain Financial Statement Items - Remaining Performance Obligations (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-08-01 $ in Millions	Jul. 31, 2023 USD ($)
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue expected to be recognized from remaining performance obligations	$ 244.6
Revenue expected to be recognized from remaining performance obligations (as percent)	42%
Revenue expected to be recognized from remaining performance obligations (in months)	12 months

Debt - Schedule of Convertible

Debt - Schedule of Convertible Debt (Details) - Convertible Senior Notes - 2027 Convertible Notes (on an as-converted basis) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023	Apr. 30, 2022
Debt Instrument [Line Items]
Gross amount	$ 300,000	$ 300,000
Debt discount and issuance costs	(4,461)	(5,064)
Carrying amount	295,539	294,936	$ 294,000
Estimated fair value (Level 2 Inputs)	$ 227,000	$ 233,000

Debt - Schedule of Interest Exp

Debt - Schedule of Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Debt Disclosure [Abstract]
Contractual interest expense	$ 2,625	$ 2,625	$ 5,250	$ 3,500
Amortization of debt discount and issuance costs	301	303	603	362
Total interest expense	$ 2,926	$ 2,928	$ 5,853	$ 3,862

Debt - Narrative (Details)

Debt - Narrative (Details)		1 Months Ended
	Jul. 27, 2023 USD ($)	Apr. 30, 2022 USD ($) day $ / shares	Jul. 31, 2023 USD ($)	Jan. 31, 2023 USD ($)
Convertible Senior Notes | 2027 Convertible Notes (on an as-converted basis)
Debt Instrument [Line Items]
Debt instrument, face amount		$ 300,000,000
Debt		$ 294,000,000	$ 295,539,000	$ 294,936,000
Conversion ratio		0.0416119
Conversion price (usd per share) | $ / shares		$ 24.03
Ratio of repurchase price to principal amount		100%
Ratio of control price to principal amount		125%
Interest rate, effective percentage			3.93%
Long-term debt, fair value			$ 227,000,000	$ 233,000,000
Convertible Senior Notes | 2027 Convertible Notes (on an as-converted basis) | Period One
Debt Instrument [Line Items]
Threshold trading days | day		20
Threshold consecutive trading days | day		30
Threshold percentage of stock price trigger		130%
Convertible Senior Notes | 2027 Convertible Notes (on an as-converted basis) | Period Two
Debt Instrument [Line Items]
Threshold trading days | day		5
Threshold consecutive trading days | day		10
Threshold percentage of stock price trigger		98%
Convertible Senior Notes | 2027 Convertible Notes (on an as-converted basis) | Cash Interest
Debt Instrument [Line Items]
Interest rate, stated percentage		3.50%
Convertible Senior Notes | 2027 Convertible Notes (on an as-converted basis) | Paid In Kind Interest
Debt Instrument [Line Items]
Interest rate, stated percentage		5%
Convertible Senior Notes | Secured Debt
Debt Instrument [Line Items]
Maximum covenant threshold		$ 750,000,000
Trustee percentage (as a percent)		25%
Declare percentage		100%
2027 Revolving Credit Facility | Line of Credit | Revolving Credit Facility
Debt Instrument [Line Items]
Interest rate, stated percentage	1.75%
Maximum borrowing capacity	$ 150,000,000
Commitment fee	0.40%
Borrowing capacity	$ 150,000,000
2027 Revolving Credit Facility | Line of Credit | Revolving Credit Facility | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Basis spread on variable rate	2.75%
Participation fee	2.25%
Borrowing outstanding			0
2027 Revolving Credit Facility | Line of Credit | Revolving Credit Facility | Euro Interbank Offered Rate (EURIBOR)
Debt Instrument [Line Items]
Basis spread on variable rate	2.75%
2027 Revolving Credit Facility | Line of Credit | Revolving Credit Facility | Daily Simple Risk-Free Rate
Debt Instrument [Line Items]
Basis spread on variable rate	2.75%
2027 Revolving Credit Facility | Line of Credit | Letter of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 100,000,000
2027 Revolving Credit Facility | Line of Credit | Letter of Credit | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Borrowing outstanding			$ 0

Commitment and Contingencies -

Commitment and Contingencies - Narrative (Details) - USD ($) $ in Millions	Jul. 31, 2023	Jan. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Letters of credit outstanding	$ 30.4	$ 30.4

Commitment and Contingencies _2

Commitment and Contingencies - Schedule of Future Minimum Lease Payments Under All Non-cancellable Operating Leases (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]
2024 (remaining six months)	$ 3,532
2025	6,220
2026	5,016
2027	4,710
2028	4,103
Thereafter	6,252
Total undiscounted operating lease payments	29,833
Less: imputed interest	(6,028)
Total operating lease liabilities	23,805
Less: current portion of operating lease liabilities	(4,261)
Operating lease liabilities, noncurrent	$ 19,544	$ 21,841

Common Stock (Details)

Common Stock (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	3 Months Ended	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2023	Jan. 31, 2023	Jul. 01, 2022
Class of Stock [Line Items]
Common stock, shares authorized (in shares)		1,000,000,000	1,000,000,000	1,000,000,000
Common stock, par value (in USD per share)		$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares outstanding (in shares)		359,792,252	359,792,252	348,330,481
Common stock, shares issued (in shares)		359,792,252	359,792,252	348,330,481
At-The-Market Offering
Class of Stock [Line Items]
Common stock, shares authorized (in shares)					1,000,000,000
Maximum consideration receivable	$ 500
Number of shares sold (in shares)		4,076,072	5,985,100
Consideration received on sold shares		$ 37.3	$ 54.8
Issuance costs		0.4	0.6
Shares available for future issuance		$ 394.6	$ 394.6

Stock Warrants - Narrative (Det

Stock Warrants - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	6 Months Ended
	Jul. 31, 2023	Jul. 31, 2023	Jul. 31, 2022	Jan. 31, 2023	Feb. 21, 2022
Legacy Chargepoint | Common Stock
Class of Warrant or Right [Line Items]
Issuance of common stock upon exercise of warrants (in shares)			13,223
Legacy Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)	34,499,436	34,499,436		34,499,436
Warrants exercised (in shares)		0
Proceeds from the exercise of warrants			$ 0
Legacy Warrants | Legacy Chargepoint | Common Stock
Class of Warrant or Right [Line Items]
Warrants exercised (in shares)	0	0	14,568
Private Placement Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)	0	0
Warrant per common share (in dollars per share)					$ 0.355

Stock Warrants - Warrant Activi

Stock Warrants - Warrant Activity (Details) - Legacy Warrants	6 Months Ended
	Jul. 31, 2023 shares
Warrants Or Rights Outstanding Roll Forward [Roll Forward]
Outstanding at beginning of period (in shares)	34,499,436
Warrants exercised (in shares)	0
Outstanding at end of period (in shares)	34,499,436

Equity Plans and Stock-based _3

Equity Plans and Stock-based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 35,099	$ 26,419	$ 59,063	$ 41,946
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	1,938	1,341	2,933	2,126
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	15,847	11,420	25,353	17,398
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	6,757	5,285	10,926	7,831
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 10,557	$ 8,373	$ 19,851	$ 14,591

Equity Plans and Stock-based _4

Equity Plans and Stock-based Compensation - Narrative (Details) $ in Millions	3 Months Ended	6 Months Ended
	Jul. 31, 2023 USD ($) shares	Jul. 31, 2023 USD ($) shares
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Unrecognized stock-based compensation cost | $	$ 228.5	$ 228.5
Period for recognition (in years)		2 years 11 months 19 days
2021 Equity Incentive Plan
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Common stock reserved (in shares)	44,405,539	44,405,539
Number of stock options granted (in shares)	0	0
Employee stock purchase plan
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Common stock reserved (in shares)	13,842,252	13,842,252

Equity Plans and Stock-based _5

Equity Plans and Stock-based Compensation - Restricted Stock Units Activity (Details) - Restricted stock units	6 Months Ended
	Jul. 31, 2023 $ / shares shares
Number of Shares
Outstanding, beginning balance (in shares) | shares	12,935,413
Granted (in shares) | shares	13,600,840
Vested (in shares) | shares	(2,813,610)
Forfeited (in shares) | shares	(959,444)
Outstanding, ending balance (in shares) | shares	22,763,199
Weighted Average Grant Date Fair Value per Share
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 15.02
Granted (in dollars per share) | $ / shares	8.68
Vested (in dollars per share) | $ / shares	14.37
Forfeited (in dollars per share) | $ / shares	13.97
Outstanding, ending balance (in dollars per share) | $ / shares	$ 11.36

Equity Plans and Stock-based _6

Equity Plans and Stock-based Compensation - Performance Restricted Stock Units Activity (Details) - Performance Shares	6 Months Ended
	Jul. 31, 2023 $ / shares shares
Number of Shares
Outstanding, beginning balance (in shares) | shares	2,147,366
Granted (in shares) | shares	60,892
Forfeited (in shares) | shares	(143,266)
Outstanding, ending balance (in shares) | shares	2,064,992
Weighted Average Grant Date Fair Value per Share
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 10.83
Granted (in dollars per share) | $ / shares	8.21
Forfeited (in dollars per share) | $ / shares	10.47
Outstanding, ending balance (in dollars per share) | $ / shares	$ 10.77

Equity Plans and Stock-based _7

Equity Plans and Stock-based Compensation - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jul. 31, 2023	Jan. 31, 2023
Number of Stock Option Awards
Outstanding as of beginning of period (in shares)	17,600,524
Options exercised (in shares)	(2,103,163)
Forfeited (in shares)	(130,985)
Outstanding as end of period (in shares)	15,366,376	17,600,524
Options vested and expected to vest at end of period (in shares)	15,363,337
Exercisable at end of period (in shares)	13,120,974
Weighted Average Exercise Price
Outstanding as of beginning of period (USD per share)	$ 0.70
Options exercised (USD per share)	0.64
Forfeited (USD per share)	0.77
Outstanding as of end of period (USD per share)	0.71	$ 0.70
Options vested and expected to vest as of end of period (USD per share)	0.71
Exercisable as of end of period (USD per share)	$ 0.70
Weighted Average Remaining Contractual term (in years)
Outstanding (in years)	5 years 4 months 24 days	5 years 7 months 6 days
Options vested and expected to ves (in years)	5 years 4 months 24 days
Exercisable (in years)	5 years 1 month 6 days
Aggregate Intrinsic Value (in thousands)
Outstanding	$ 122,193	$ 201,352
Options vested and expected to vest	122,169
Exercisable	$ 104,454

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Income Tax Disclosure [Abstract]
Effective income tax rate	(0.70%)	0.40%	(0.20%)	1.20%

Basic and Diluted Net Loss pe_3

Basic and Diluted Net Loss per Share - Computation of Basic and Diluted Loss per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Jul. 31, 2023	Apr. 30, 2023	Jul. 31, 2022	Apr. 30, 2022	Jul. 31, 2023	Jul. 31, 2022
Numerator:
Net loss	$ (125,255)	$ (79,388)	$ (92,700)	$ (89,266)	$ (204,643)	$ (181,966)
Denominator:
Weighted average common shares outstanding (in shares)	355,893,921		336,911,941		353,031,968	335,845,756
Less: Weighted-average unvested restricted shares and shares subject to repurchase (in shares)	(17,114)		(98,386)		(23,495)	(108,984)
Weighted average shares outstanding - basic (in shares)	355,876,807		336,813,555		353,008,473	335,736,772
Weighted average shares outstanding - diluted (in shares)	355,876,807		336,813,555		353,008,473	335,736,772
Net loss per share - basic (in USD per share)	$ (0.35)		$ (0.28)		$ (0.58)	$ (0.54)
Net loss per share - diluted (in USD per share)	$ (0.35)		$ (0.28)		$ (0.58)	$ (0.54)

Basic and Diluted Net Loss pe_4

Basic and Diluted Net Loss per Share - Antidilutive Securities (Details) - shares	6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents	87,864,643	82,495,890
2027 Convertible Notes (on an as-converted basis)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents	12,483,569	12,483,569
Options to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents	15,366,376	19,280,776
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents	22,763,199	13,377,719
Unvested early exercised common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents	12,178	89,877
Common stock warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents	34,499,436	35,524,021
Employee stock purchase plan
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents	2,739,885	1,739,928

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event - Reorganization $ in Millions	Sep. 06, 2023 USD ($)
Subsequent Event [Line Items]
Reduction in workforce	10%
Restructuring, expected charges	$ 8